Free Trial

Privia Health Group (PRVA) Stock Price, News & Analysis

Privia Health Group logo
$23.34 +0.05 (+0.21%)
Closing price 03/21/2025 04:00 PM Eastern
Extended Trading
$23.43 +0.09 (+0.38%)
As of 03/21/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Privia Health Group Stock (NASDAQ:PRVA)

Key Stats

Today's Range
$22.90
$23.42
50-Day Range
$20.74
$25.69
52-Week Range
$15.92
$26.04
Volume
1.47 million shs
Average Volume
755,001 shs
Market Capitalization
$2.81 billion
P/E Ratio
233.42
Dividend Yield
N/A
Price Target
$26.67
Consensus Rating
Buy

Company Overview

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Remove Ads

Privia Health Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
74th Percentile Overall Score

PRVA MarketRank™: 

Privia Health Group scored higher than 74% of companies evaluated by MarketBeat, and ranked 212th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Privia Health Group has received a consensus rating of Buy. The company's average rating score is 3.06, and is based on 13 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Privia Health Group has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Privia Health Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Privia Health Group are expected to grow by 92.86% in the coming year, from $0.14 to $0.27 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Privia Health Group is 233.42, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.48.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Privia Health Group is 233.42, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.74.

  • Price to Earnings Growth Ratio

    Privia Health Group has a PEG Ratio of 3.47. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Privia Health Group has a P/B Ratio of 4.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Privia Health Group's valuation and earnings.
  • Percentage of Shares Shorted

    3.88% of the float of Privia Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Privia Health Group has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in Privia Health Group has recently decreased by 11.16%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Privia Health Group does not currently pay a dividend.

  • Dividend Growth

    Privia Health Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.88% of the float of Privia Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Privia Health Group has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in Privia Health Group has recently decreased by 11.16%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Privia Health Group has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Privia Health Group this week, compared to 3 articles on an average week.
  • Search Interest

    4 people have searched for PRVA on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Privia Health Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.20% of the stock of Privia Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    94.48% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Privia Health Group's insider trading history.
Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

PRVA Stock News Headlines

Needham Reaffirms Their Buy Rating on Privia Health Group (PRVA)
Your Wealth is Under Attack
Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold.
Privia Health Group (PRVA) Gets a Buy from Stifel Nicolaus
Privia Health price target raised to $30 from $29 at Canaccord
See More Headlines

PRVA Stock Analysis - Frequently Asked Questions

Privia Health Group's stock was trading at $19.55 at the start of the year. Since then, PRVA stock has increased by 19.4% and is now trading at $23.34.
View the best growth stocks for 2025 here
.

Privia Health Group, Inc. (NASDAQ:PRVA) issued its quarterly earnings results on Thursday, August, 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by $0.02. The business's revenue was up 2.2% on a year-over-year basis.

Privia Health Group (PRVA) raised $351 million in an IPO on Thursday, April 29th 2021. The company issued 19,500,000 shares at $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Top institutional investors of Privia Health Group include FMR LLC (15.17%), Durable Capital Partners LP (9.57%), Vanguard Group Inc. (9.52%) and Riverbridge Partners LLC (4.85%). Insiders that own company stock include Adam Boehler, William M Sullivan, Jeffrey B Butler, David Mountcastle, Parth Mehrotra, Advisors LLC Mbd, Thomas Bartrum, Matthew Shawn Morris and Thomas A Mccarthy.
View institutional ownership trends
.

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Privia Health Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
8/08/2024
Today
3/23/2025
Next Earnings (Estimated)
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Health services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:PRVA
Fax
N/A
Employees
1,102
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$26.67
High Stock Price Target
$40.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+14.3%
Consensus Rating
Buy
Rating Score (0-4)
3.06
Research Coverage
16 Analysts

Profitability

Trailing P/E Ratio
233.42
Forward P/E Ratio
166.71
P/E Growth
3.47
Net Income
$23.08 million
Pretax Margin
1.41%

Debt

Sales & Book Value

Annual Sales
$1.74 billion
Cash Flow
$0.24 per share
Price / Cash Flow
98.24
Book Value
$5.14 per share
Price / Book
4.54

Miscellaneous

Free Float
102,961,000
Market Cap
$2.81 billion
Optionable
Optionable
Beta
0.85
The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report

This page (NASDAQ:PRVA) was last updated on 3/23/2025 by MarketBeat.com Staff
From Our Partners